Pharma Stocks
-
The recent 11% gain must have brightened CEO Ramesh Potluri’s week, SMS Pharmaceuticals Limited’s (NSE:SMSPHARMA) most bullish insider
Key Insights Insiders appear to have a vested interest in SMS Pharmaceuticals’ growth, as seen by their sizeable ownership 52%…
Read More » -
Assessing Merck (MRK) Valuation After Recent Share Price Momentum And Modest Overvaluation Signal
Merck (MRK) is back in focus after recent trading, with the stock closing at $108.87 and short term returns showing…
Read More » -
Defensive Pharma Stock At A Crossroads As Analysts Turn Cautiously Constructive
Almirall S.A., Almirall stock 07.01.2026 – 12:55:12 Almirall S.A. has quietly outperformed much of the European healthcare space over the…
Read More » -
Mankind Pharma Sees Sharp Open Interest Surge Amid Bullish Market Positioning
Open Interest and Volume Dynamics On 7 January 2026, Mankind Pharma Ltd (symbol: MANKIND) recorded a substantial increase in open…
Read More » -
Bliss GVS Pharma’s (NSE:BLISSGVS) 37% CAGR outpaced the company’s earnings growth over the same three-year period
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money…
Read More » -
Is This Big Pharma OG a Secret Comeback Play or Total Trap?
Pfizer, Stock 06.01.2026 – 17:58:05 Pfizer’s stock has been wrecked since the Covid hype peak, but Wall Street is quietly…
Read More » -
Tonix Pharmaceuticals (TNXP) to present at Jan. 2026 conferences
Tonix Pharmaceuticals (Nasdaq: TNXP) announced that CEO Seth Lederman, M.D. will present and host investor meetings at two January 2026…
Read More » -
Bliss GVS Pharma Ltd Hits Intraday High with 8.38% Surge on 6 Jan 2026
Intraday Trading Highlights The stock opened with a positive gap, rising 2.09% from its previous close, signalling early bullish momentum.…
Read More » -
Emcure Pharmaceuticals Limited’s (NSE:EMCURE) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Most readers would already be aware that Emcure Pharmaceuticals’ (NSE:EMCURE) stock increased significantly by 6.7% over the past month. Given…
Read More » -
This Flying-Under-the-Radar Pharma Stock Pays Nearly 7% (While Everyone’s Sleeping)
The end of a short-lived, COVID-related revenue surge has brought Pfizer’s stock lower. But sellers have ignored all the developmental…
Read More »